CreatorsPublishersAdvertisers
View more in
Boston, MA

The Evolving Treatment Landscape of HNSCC

onclive.com
 2021-07-19

Cover picture for the articleA brief overview of treatment advances for HRAS-mutated head and neck squamous cell carcinoma. Glenn J. Hanna, MD: Hello, my name is Glenn Hanna. I’m a medical oncologist in the Center for Head and Neck Oncology at Dana-Farber Cancer Institute in Boston, Massachusetts. I’m joined today by Dr Nabil Saba. He is the head and neck cancer program director at Emory University in Atlanta, Georgia. We’re thrilled to talk to you a bit today about the HRAS-mutated head and neck cancer landscape.

www.onclive.com

Comments / 0

Comments / 0